U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951632) titled 'Allogeneic iNKT Cells in AS: Immune Remodeling Study' on Nov. 16.
Brief Summary: This study observes patients with ankylosing spondylitis (AS) who are receiving, or have received, multiple infusions of allogeneic invariant natural killer T (iNKT) cells as a treatment. Allogeneic iNKT cells are immune cells taken from a healthy donor, grown in the laboratory, and given to patients by infusion.
The treatment infusions are given under a separate treatment protocol. This study does not give any treatment. It only collects blood samples and analyzes them to learn how the immune system changes during and after the cell infusions.
Resear...